149 related articles for article (PubMed ID: 23140283)
1. Anticarcinogenic actions of tributyrin, a butyric acid prodrug.
Heidor R; Ortega JF; de Conti A; Ong TP; Moreno FS
Curr Drug Targets; 2012 Dec; 13(14):1720-9. PubMed ID: 23140283
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug.
Kuroiwa-Trzmielina J; de Conti A; Scolastici C; Pereira D; Horst MA; Purgatto E; Ong TP; Moreno FS
Int J Cancer; 2009 Jun; 124(11):2520-7. PubMed ID: 19195022
[TBL] [Abstract][Full Text] [Related]
3. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
4. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies.
Pouillart PR
Life Sci; 1998; 63(20):1739-60. PubMed ID: 9820119
[TBL] [Abstract][Full Text] [Related]
5. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis.
Heidor R; de Conti A; Ortega JF; Furtado KS; Silva RC; Tavares PE; Purgatto E; Ract JN; de Paiva SA; Gioielli LA; Pogribny IP; Moreno FS
Mol Nutr Food Res; 2016 Feb; 60(2):420-9. PubMed ID: 26548572
[TBL] [Abstract][Full Text] [Related]
6. The chemopreventive activity of the histone deacetylase inhibitor tributyrin in colon carcinogenesis involves the induction of apoptosis and reduction of DNA damage.
Heidor R; Furtado KS; Ortega JF; de Oliveira TF; Tavares PE; Vieira A; Miranda ML; Purgatto E; Moreno FS
Toxicol Appl Pharmacol; 2014 Apr; 276(2):129-35. PubMed ID: 24576724
[TBL] [Abstract][Full Text] [Related]
7. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
Chen Z; Wang W; Pan J; Chen L; Xue Y
Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
[TBL] [Abstract][Full Text] [Related]
8. Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseases.
Nudelman A; Gnizi E; Katz Y; Azulai R; Cohen-Ohana M; Zhuk R; Sampson SR; Langzam L; Fibach E; Prus E; Pugach V; Rephaeli A
Eur J Med Chem; 2001 Jan; 36(1):63-74. PubMed ID: 11231050
[TBL] [Abstract][Full Text] [Related]
9. Volatile Retention and Morphological Properties of Microencapsulated Tributyrin Varied by Wall Material and Drying Method.
Donovan JD; Cadwallader KR; Lee Y
J Food Sci; 2016 Mar; 81(3):E643-50. PubMed ID: 26878682
[TBL] [Abstract][Full Text] [Related]
10. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat.
Parodi PW
J Dairy Sci; 1999 Jun; 82(6):1339-49. PubMed ID: 10386321
[TBL] [Abstract][Full Text] [Related]
11. Butyric acid and tributyrin induce apoptosis in human hepatic tumour cells.
Watkins SM; Carter LC; Mak J; Tsau J; Yamamoto S; German JB
J Dairy Res; 1999 Nov; 66(4):559-67. PubMed ID: 10612054
[TBL] [Abstract][Full Text] [Related]
12. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
de Conti A; Tryndyak V; Koturbash I; Heidor R; Kuroiwa-Trzmielina J; Ong TP; Beland FA; Moreno FS; Pogribny IP
Carcinogenesis; 2013 Aug; 34(8):1900-6. PubMed ID: 23568954
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
14. Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.
Kang SN; Hong SS; Lee MK; Lim SJ
Int J Pharm; 2012 May; 428(1-2):76-81. PubMed ID: 22405988
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of alkylglycerols as vehicles of butyric acid on colon cancer cells.
Molina S; Moran-Valero MI; Martin D; Vázquez L; Vargas T; Torres CF; Ramirez de Molina A; Reglero G
Chem Phys Lipids; 2013; 175-176():50-6. PubMed ID: 23973778
[TBL] [Abstract][Full Text] [Related]
16. In vitro intestinal bioaccessibility of alkylglycerols versus triacylglycerols as vehicles of butyric acid.
Martín D; Morán-Valero MI; Señoráns FJ; Reglero G; Torres CF
Lipids; 2011 Mar; 46(3):277-85. PubMed ID: 21225371
[TBL] [Abstract][Full Text] [Related]
17. Emulsion-based delivery systems for tributyrin, a potential colon cancer preventative agent.
Li Y; Le Maux S; Xiao H; McClements DJ
J Agric Food Chem; 2009 Oct; 57(19):9243-9. PubMed ID: 19731938
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
19. Cows' milk fat components as potential anticarcinogenic agents.
Parodi PW
J Nutr; 1997 Jun; 127(6):1055-60. PubMed ID: 9187617
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
de Conti A; Kuroiwa-Trzmielina J; Horst MA; Bassoli BK; Chagas CE; Purgatto E; Cavalher FP; Camargo AA; Jordão AA; Vannucchi H; Scolastici C; Ong TP; Moreno FS
J Nutr Biochem; 2012 Aug; 23(8):860-6. PubMed ID: 21940155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
